ask="0.620"
ask_size="10300"
average_daily_volume="739125"
bid="0.618"
bid_size="700"
book_value="-0.413"
change="-0.002"
change_from_200_day_moving_average="-0.078"
change_from_50_day_moving_average="-0.084"
change_from_52_week_high="-0.885"
change_From_52_week_low="0.365"
change_in_percent="-0.239%"
close="0.625"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.083"
ebitda="-1.60M"
eps_estimate_current_year="-0.080"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-0.030"
ex_dividend_date="N/A"
float_shares="139027000"
high="0.658"
high_52_weeks="1.510"
last_trade_date="1/6/2017"
last_trade_price="0.625"
last_trade_size="200"
last_trade_time="4:02pm"
low="0.616"
low_52_weeks="0.260"
market_capitalization="97.18M"
moving_average_200_day="0.703"
moving_average_50_day="0.709"
name="Navidea Biopharmaceuticals
Inc"
notes="N/A"
one_year_target_price="1.250"
open="0.630"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-11.043%"
percent_change_from_50_day_moving_average="-11.821%"
percent_change_from_52_week_high="-58.609%"
percent_change_from_52_week_low="+140.200%"
previous_close="0.627"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="4.253"
revenue="22.91M"
shares_outstanding="155494000"
short_ratio="11.730"
stock_exchange="ASE"
symbol="NAVB"
volume="637813"
weeks_range_52="0.260 - 1.510"
